Home » Topics » BioWorld Science

BioWorld Science
RSS

FLX Bio presents a novel CCR4 antagonist for the treatment of allergic disorders

May 21, 2019

Early in ALS/FTD, there's targetable toxicity

May 21, 2019

Broken BBB exposes targeting mechanism

May 21, 2019

New phase II trial studies TQB-2450 in relapsed or refractory classical Hodgkin's lymphoma

May 20, 2019

Travoprost implant OTX-TIC safe, improves intraocular pressure in phase I trial

May 20, 2019

FDA approves Gattex for pediatric patients with short bowel syndrome

May 20, 2019

Genentech describes RIPK1 inhibitors

May 20, 2019

Merck & Co. divulges new HCV inhibitors

May 20, 2019

Interim analysis of INTELLANCE-1 study of Depatux-M in GBM shows no survival benefit

May 20, 2019

Yumanity Therapeutics synthesizes new SCD1 and SCD5 inhibitors

May 20, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...